Global Cell Therapy Market 2017-2021

About Cell Therapy

Cell therapy products, which are derived from stem cells, tissues, and organs grown in laboratories, are injected into patients. The growing number of clinical trials, government and private funding, and increasing number of partnerships between companies are driving the growth of the global cell therapy market. Cell therapy products that are available in the market are based on autologous and allogenic cells. The demand of cell therapy treatment is increasing. This is because cell therapy products can be used for personalized treatment.

Technavio’s analysts forecast the global cell therapy market to grow at a CAGR of 23.27% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global cell therapy market for 2017-2021. The report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA

Technavio's report, Global Cell Therapy Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
• Dendreon
• Mesoblast
• Vericel

Other prominent vendors
• AlloCure
• Amorcyte
• Anterogen
• Antibe Therapeutics
• Astellas Pharma
• Athersys
• Avita Medical
• AxoGen
• Bellicum Pharmaceuticals
• BioCardia
• BIOCELLULAR THERAPIES
• Biogen Idec
• Bio-Tissue
• BIOTIME
• BioTissue Technologies
• BrainStorm Cell Therapeutics
• Bluebird Bio
• Bone Therapeutics
• Caladrius
• Capricor Therapeutics
• CellBioMed
• Celgene
• Cell Medica
• CellPraxis
• CellSeed
• Cell Therapy
• Celyad
• CESCA THERAPEUTICS
• CRC for Cell Therapy Manufacturing
• CryoLife
• Cynata Therapeutics
• Cytori Therapeutics
• DiscGenics
• Fate Therapeutics
• Fibrocell Science
• Forticell Bioscience
• Fortress Biotech
• Gamida Cell
• GlaxoSmithKline
• Healthpoint
• Histogen
• Histogenics
• Holostem Terapie Avanzate
• Humacyte
• Immunocellular Therapeutics
• Integra Life Sciences
• Intercytex
• iSTO Technologies
• Janssen Pharma
• Juno Therapeutics
• Juventas Therapeutics
• Kensey Nash
• Kite Pharma
• Kiadis Pharma
• LifeNet Health
• Living Cell Technologies
• Lonza
• MaxCyte
• MEDIPOST
• Nanofiber Solutions
• Nanotope
• Neuralstem
• Newlink Genetics
• Northwest Biotherapeutics
• NovaRx
• Ocata Therapeutics
• Opexa Therapeutics
• Orbsen Therapeutics
• Pfizer
• Pharmicell
• Pluristem Therapeutics
• Prima BioMed
• Q Therapeutics
• Regenerexx
• Regeneus
• Regenerys
• Regience
• Regrow
• RepliCel
• ReproCELL
• ReNeuron

• RenovaCare
• RESSTORE
• RhinoCyte
• Rohto Pharmaceutical
• SanBio
• Sangamo BioSciences
• Shanghai Sunway Biotech
• Shire Regenerative Medicine
• StemCells
• STEMPEUTICS RESEARCH
• Synergistic Technologies
• t2cure
• Takara Bio
• tella
• Tengion
• TissueGene
• Tessa Therapeutics
• Txcell
• VentriNova
• ViaCyte
• VistaGen Therapeutics
• SDRMI and Xcelthera

Market driver
• Increase in prevalence of chronic diseases
• For a full, detailed list, view our report

Market challenge
• High cost of clinical trials and cell therapy doses
• For a full, detailed list, view our report

Market trend
• Proliferation of strategic alliances and royalty payments
• For a full, detailed list, view our report

Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

Frequently Asked Questions